Original articles

Mechanism of Huayu Qutan recipe (化瘀祛痰方) anti-atherosclerosis mediates lipophagy via mammalian target of rapamycin complex 1/ transcription factor EB signaling pathway in ApoE-/-mice

  • Yue LI ,
  • Jiaxiang PAN ,
  • Guanlin YANG ,
  • Jiajia YU ,
  • Xize WU ,
  • Dongyu MIN ,
  • Meijia CHENG ,
  • Dongdong YU ,
  • Minghua NAN ,
  • Xiaoyu GAO ,
  • Linlin PANG ,
  • Lihong GONG ,
  • Lianqun JIA
Expand
  • 1 Department of Cardiology, the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110032, China
    2 Liaoning Provincial Key Laboratory of TCM Geriatric Cardio-Cerebrovascular Diseases, Shenyang 110032, China
    3 Innovation Engineering Technology Center of Traditional Chinese Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang 110847, China
    4 Postdoctoral Program of Liaoning University of Traditional Chinese Medicine, Shenyang 110847, China
    5 Graduate School of Liaoning University of Traditional Chinese Medicine, Shenyang 110847, China
    6 Experimental Center of Traditional Chinese Medicine, the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110032, China
    7 Department of Osteology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110032, China
    8 Key Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications of Liaoning University of Traditional Chinese Medicine, Shenyang 110847, China
    9 Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110000, China
    10 Department of Oncology department, Shengjing Hospital affiliated to China Medical University, Shenyang 110000, China

Received date: 2023-12-12

  Accepted date: 2024-05-15

  Online published: 2025-03-10

Supported by

Science and Technology Research Project of Education Department of Liaoning Province: the Mechanism of Regulating Lipophagy and Affecting Cholesterol Efflux in Human Promyelocytic Leukemia Cell Line Macrophages by Huayu Qutan Recipe based on the Theory of "Laoxia Shengtan"(L202048);Youth Project of Basic Scientific Research Project of Education Department of Liaoning Province: Mechanism of Mitochondrial Autophagy and Apoptosis in L02 Hepatocytes Regulated by miR-7043-3p based on the Theory of "Spleen Qi Dispersing Essence" of Huayu Qutan Recipe(LJKQZ2021064)

Abstract

OBJECTIVE: To investigate the effects of Huayu Qutan recipe (化瘀祛痰方, HYQT) on the atherosclerosis (AS) model of ApoE-/- mice with a high-fat diet and to illustrate the underlying mechanisms from modern patho-physiological conceptualizations.

METHODS: High performance liquid chromatography of quadrupole time of flight-tandem mass spectrometry (HPLC-Q-TOF-MS/MS) analysis was used to identify the active compounds in the recipe. The mice were randomly allocated into 7 groups: control (CTRL) group, normal diet (ND) group, high-fat diet (HFD) group, HYQT groups (low dose, medium dose, and high dose), and simvastatin (SIM) group. Deferent doses of HYQT were gavaged twice a day, and then the protective effect of HYQT on plaque formation in ApoE-/- mice with a high-fat diet was verified viahematoxylin-eosin (HE) staining and oil red o (ORO) staining. We observed the co-localization in aortic macrophages and lipid droplets (LDs) by CD68 and the Bodipy fluorescence probe. Light chain 3 phosphoprotein class Ⅱ/light chain 3 phosphoprotein class Ⅰ (LC3Ⅱ/LC3Ⅰ) was examined by western blotting, and sequestosome 1 (SQSTM1/p62), Beclin1, Lamp1, mammalian target of rapamycin (mTOR), phosphorylated mammalian target of rapamycin (p-mTOR), and ATP-binding cassette transporter A1 (ABCA1) were examined by real-time polymerase chain reaction (RT-PCR) and Western blotting. Transcription factor EB (TFEB) nuclear translocation was determined by immunofluorescence analysis.

RESULTS: Five active compounds were identified using HPLC-Q-TOF-MS/MS analysis: ferulic acid, chlorogenic acid, calycosin, formononetin, and 8,2'-dihydroxy-7,4'-dimethoxy-isoflavane. The effect of HYQT on atherosclerotic plaque formation in ApoE-/- mice was investigated. These findings showed that HYQT decreased the co-localization of CD68 and Bodipy and increased the co-localization of CD68 and LC3B. Medium and high doses of HYQT increased autophagosome formation and promoted the maturation of LC3Ⅱ/LC3Ⅰ. Additionally, HYQT decreased the expression of SQSTM1/p62. Medium and high doses of HYQT also increased the expression of Beclin1 and Lamp1. RT-PCR and Western blot results suggested that HYQT enhanced the expression of ABCA1 mRNA and protein and regulated the mTORC1/TFEB signaling pathway.

CONCLUSION: The results indicate that HYQT is an effective traditional Chinese herbal remedy for the treatment of AS. HYQT mitigates macrophage-derived foam cell formation by activating autophagy in atherosclerosis. The mTOR/TFEB signaling pathway and ABCA1 are therapeutic targets of HYQT for the treatment of AS.

Cite this article

Yue LI , Jiaxiang PAN , Guanlin YANG , Jiajia YU , Xize WU , Dongyu MIN , Meijia CHENG , Dongdong YU , Minghua NAN , Xiaoyu GAO , Linlin PANG , Lihong GONG , Lianqun JIA . Mechanism of Huayu Qutan recipe (化瘀祛痰方) anti-atherosclerosis mediates lipophagy via mammalian target of rapamycin complex 1/ transcription factor EB signaling pathway in ApoE-/-mice[J]. Journal of Traditional Chinese Medicine, 2025 , 45(2) : 291 -302 . DOI: 10.19852/j.cnki.jtcm.2025.02.016

References

1. World Health Organization. Cardiovascular diseases (CVDs), 2020-03-14, cited 2021-06-11. Available from URL: https://www.who.int/zh/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
2. Libby P, Buring JE, Badimon L, et al. Atherosclerosis. Nat Rev Dis Primers 2019; 5: 56.
3. Ward NC, Watts GF, Eckel RH. Statin toxicity. Circ Res 2019; 124: 328-50.
4. Li YC (Qing dynasty). Zheng Zhi Hui Bu. Beijing: China Traditional Chinese Medicine Press, 2005: 15.
5. Zhang Z, Hu J. Recent advances and perspective of studies on phlegm syndrome in Chinese Medicine. Evid Based Complement Alternat Med 2016; 2016: 6463270.
6. Bai D, Song J. Plasma metabolic biomarkers for syndrome of phlegm and blood stasis in hyperlipidemia and atherosclerosis. J Tradit Chin Med 2012; 32: 578-83.
7. Su C, Li N, Ren R, et al. Progress in the medicinal value, bioactive compounds, and pharmacological activities of gynostemma pentaphyllum. Molecules 2021; 26: 6249.
8. Huang W, Yang Y, Zeng Z, et al. Effect of Salvia Miltiorrhiza and ligustrazine injection on myocardial ischemia/reperfusion and hypoxia/reoxygenation injury. Mol Med Rep 2016; 144537-44.
9. Wang Q, Yuan LL, Zhang YL, et al. Research on network pharmacology of Acori Tatarinowii Rhizoma combined with Curcumae Radix in treating epilepsy. Zhong Guo Zhong Yao Za Zhi 2019; 44: 2701-8.
10. Man YC, Yang C, Wang XT, et al. Effect of Huayu Qutan decoction recipe on liver lipid injury in atherosclerotic rabbits by regulating autophagy through PI3K/Akt/mTOR signal pathway. Zhong Hua Zhong Yi Yao Xue Kan 2019; 37: 1913-6+2058.
11. Pei YP, Chen ZH, Meng XY, et al. Mechanism of prevention and treatment of arteriosclerosis by Jianpi Qutan Huayu formula regulating miR-155/Rheb/mTOR pathway to mediate autophagy of endothelial cells. Zhong Hua Zhong Yi Yao Xue Kan 2022; 40: 29-34+262-3.
12. Sun YM, Jia LQ, Zhang N, et al. Effect of Huayu Qutan recipe on liver mediated autophagy related gene mTOR in hyperlipidemia rats. Zhong Hua Zhong Yi Yao Xue Kan 2017; 35: 3143-6.
13. Zheng Q, Jia LQ, Song N, et al. Study on inhibitory effect of Huayu Qutan recipe on myocardial fibrosis in atherosclerotic rabbits based on mitochondrial Fusion-lysis. Zhong Guo Shi Yan Fang Ji Xue Za Zhi 2020; 26: 71-7.
14. Pi S, Mao L, Chen J, et al. The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis. Autophagy 2021; 17: 980-1000.
15. Wang N, Westerterp M. ABC Transporters, Cholesterol efflux, and implications for cardiovascular diseases. Adv Exp Med Biol 2020; 1276: 67-83.
16. Chistiakov DA, Melnichenko AA, Myasoedova VA, et al. Mechanisms of foam cell formation in atherosclerosis. J Mol Med (Berl) 2017; 95: 1153-65.
17. Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest 2015; 125: 25-32.
18. Roczniak-Ferguson A, Petit CS, Froehlich F, et al. The transcription factor TFEB links mTORC 1 signaling to transcriptional control of lysosome homeostasis. Sci Signal 2012; 5: ra42.
19. Settembre C, Zoncu R, Medina DL, et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. Embo J 2012; 31: 1095-108.
20. Martina JA, Diab HI, Brady OA, et al. TFEB and TFE3 are novel components of the integrated stress response. Embo J 2016; 35: 479-95.
21. Nezich CL, Wang C, Fogel AI, et al. MiT/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5. J Cell Biol 2015; 210: 435-50.
22. Raben N, Puertollano R. TFEB and TFE3: linking lysosomes to cellular adaptation to stress. Annu Rev Cell Dev Biol 2016; 32: 255-78.
23. Ren H, Wang D, Zhang L, et al. Catalpol induces autophagy and attenuates liver steatosis in ob/ob and high-fat diet-induced obese mice. Aging (Albany NY) 2019; 11: 9461-77.
24. Wang D, Hiebl V, Xu T, et al. Impact of natural products on the cholesterol transporter ABCA1. J Ethnopharmacol 2020; 249: 112444.
25. Ahmadi A, Argulian E, Leipsic J, et al. From subclinical atherosclerosis to plaque progression and acute coronary events: JACC state-of-the-art review. J Am Coll Cardiol 2019; 74: 1608-17.
26. Bai T, Li M, Liu Y, et al. Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell. Free Radic Biol Med 2020; 160: 92-102.
27. Zhang Z, Zhang T, Dong K. Icariin upregulates phosphorylated cyclic adenosine monophosphate response element binding protein levels in the hippocampus of the senescence- accelerated mouse. Neural Regen Res 2012; 7: 885-90.
28. Bigford GE, Szeto A, Kimball J, et al. Cardiometabolic risks and atherosclerotic disease in ApoE knockout mice: effect of spinal cord injury and salsalate anti-inflammatory pharmacotherapy. PLoS One 2021; 16: e0246601.
29. Li D, Rui YX, Guo SD, et al. Ferulic acid: a review of its pharmacology, pharmacokinetics and derivatives. Life Sci 2021; 284: 119921.
30. Lukitasari M, Saifur Rohman M, Nugroho DA, et al. Cardiovascular protection effect of chlorogenic acid: focus on the molecular mechanism. F1000Res 2020; 9: 1462.
31. Wu C, Luan H, Zhang X, et al. Chlorogenic acid protects against atherosclerosis in ApoE-/- mice and promotes cholesterol efflux from RAW264.7 macrophages. PLoS One 2014; 9: e95452.
32. Pan L, Zhang XF, Wei WS, et al. The cardiovascular protective effect and mechanism of calycosin and its derivatives. Chin J Nat Med 2020; 18: 907-15.
33. Ma C, Xia R, Yang S, et al. Formononetin attenuates atherosclerosis via regulating interaction between KLF4 and SRA in apoE(-/-) mice. Theranostics 2020; 10: 1090-106.
34. Fardoun MM, Maaliki D, Halabi N, et al. Flavonoids in adipose tissue inflammation and atherosclerosis: one arrow, two targets. Clin Sci (Lond) 2020; 134: 1403-32.
35. Zhao J, Yu QT, Li P, et al. Determination of nine active components in Radix Hedysari and Radix Astragali using capillary HPLC with diode array detection and MS detection. J Sep Sci 2008; 31: 255-61.
36. He J, Zhang G, Pang Q, et al. SIRT6 reduces macrophage foam cell formation by inducing autophagy and cholesterol efflux under ox-LDL condition. FEBS J 2017; 284: 1324-37.
37. Li X, Xu M, Pitzer AL, et al. Control of autophagy maturation by acid sphingomyelinase in mouse coronary arterial smooth muscle cells: protective role in atherosclerosis. J Mol Med (Berl) 2014; 92: 473-85.
Outlines

/